These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15934259)
1. Managing diabetes. Recommendations and caveats. Harris S Can Fam Physician; 2005 May; 51(5):637-9, 644-6. PubMed ID: 15934259 [No Abstract] [Full Text] [Related]
2. Rosiglitazone monotherapy and type 2 diabetes. Lawrence IG Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215 [No Abstract] [Full Text] [Related]
3. Bone disease, gestational diabetes mellitus, and health care. Bloomgarden ZT Diabetes Care; 2009 Jul; 32(7):e77-83. PubMed ID: 19564462 [No Abstract] [Full Text] [Related]
4. [Status of glitazones in treatment of type 2 diabetes mellitus]. Willeke A Internist (Berl); 2007 Jul; 48(7):749; author reply 749-50. PubMed ID: 17571246 [No Abstract] [Full Text] [Related]
5. Thiazolidinediones and clinical outcomes in type 2 diabetes. Retnakaran R; Zinman B Lancet; 2009 Jun; 373(9681):2088-90. PubMed ID: 19501899 [No Abstract] [Full Text] [Related]
6. Management of type 2 diabetes mellitus. Role of thiazolidinediones. Noble J; Baerlocher MO; Silverberg J Can Fam Physician; 2005 May; 51(5):683-7. PubMed ID: 15934272 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials. He K; Guo Q; Ge J; Li J; Li C; Jing Z J Clin Pharm Ther; 2022 Feb; 47(2):168-177. PubMed ID: 34363237 [TBL] [Abstract][Full Text] [Related]
8. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Xiang AH; Peters RK; Kjos SL; Marroquin A; Goico J; Ochoa C; Kawakubo M; Buchanan TA Diabetes; 2006 Feb; 55(2):517-22. PubMed ID: 16443789 [TBL] [Abstract][Full Text] [Related]
9. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints]. Schatz H Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448 [No Abstract] [Full Text] [Related]
11. [Clinical advances in diabetes]. Martin S; Scherbaum WA Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1461-2. PubMed ID: 16794976 [No Abstract] [Full Text] [Related]
12. Early combination therapy with a thiazolidinedione for the treatment of type 2 diabetes. Kanzer-Lewis G Diabetes Educ; 2003; 29(6):954-8, 961. PubMed ID: 14692369 [No Abstract] [Full Text] [Related]
13. Oral hypoglycemic agents as an alternative therapy for gestational diabetes. Hod M; Shafrir E Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693 [No Abstract] [Full Text] [Related]
14. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes. Charbonnel B Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387 [No Abstract] [Full Text] [Related]
16. Counterpoint: Oral hypoglyemic agents should be used to treat diabetic pregnant women. Coetzee EJ Diabetes Care; 2007 Nov; 30(11):2980-2. PubMed ID: 17965316 [No Abstract] [Full Text] [Related]
17. Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus. Langer O Obstet Gynecol Clin North Am; 2007 Jun; 34(2):255-74, ix. PubMed ID: 17572271 [TBL] [Abstract][Full Text] [Related]
18. [How does the PROactive Study change therapy of diabetes?]. Erdmann E MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501 [No Abstract] [Full Text] [Related]